Bayer and Merck are hammering out final terms of an agreement and could announce the transaction in the next several days, the people said, asking not to be named because the matter is not public.
German drugmaker Bayer AG is nearing an agreement to buy Merck & Co Inc's consumer healthcare unit, people familiar with the matter said, in a deal that could value the business at around USD 14 billion.
Reckitt Benckiser Group, one of the final contenders in the auction, said on Wednesday it was no longer in active talks to buy the Merck business, leaving Bayer in the pole position to win the asset, which is best known for Coppertone sunscreen and Claritin allergy medicine.
Bayer and Merck are hammering out final terms of an agreement and could announce the transaction in the next several days, the people said, asking not to be named because the matter is not public. Representatives for Bayer and Merck declined to comment.
Also read: EID Parry acquires Bayer group firm Alimtec
Reuters first reported last week that Bayer and Reckitt had emerged as forerunners in the auction with each offering roughly USD 13.5 billion, a price that could come close to USD 14 billion when the deal is finalized.
Bloomberg News reported on Thursday that Bayer entered exclusive talks with Merck.
Bayer has also edged out other rival bidders in the auction, including Procter & Gamble Co, Boehringer Ingelheim, Novartis AG and Sanofi SA, people familiar with the matter said.
Anda sedang membaca artikel tentang
Bayer nears deal to buy Merck consumer unit: Sources
Dengan url
http://kebugaranhidup.blogspot.com/2014/05/bayer-nears-deal-to-buy-merck-consumer_4.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Bayer nears deal to buy Merck consumer unit: Sources
namun jangan lupa untuk meletakkan link
Bayer nears deal to buy Merck consumer unit: Sources
sebagai sumbernya
0 komentar:
Posting Komentar